Skip to content
Research Article Open access CC BY 3.0

Exoenzymes Activity and Biofilm Production in Candida Species Isolated from Various Clinical Specimens in Benha University Hospital, Egypt

Enas Sh. Khater, Mohamed H. Al-Nory

Microbiology Research Journal International · pp. 654–667 · Published 26 Feb 2014

10.9734/BMRJ/2014/7879

Abstract

Background: The frequency of severe systemic fungal diseases has increased in the last few decades. Aims: This study was done to speciate the candida isolates, to determine their antifungal susceptibility pattern and to detect biofilm formation and exoenzymes (phospholipase and proteinase) production. Place and Duration of Study: This is a Six-months Cross sectional study conducted in ICU and Microbiology & Immunology departments, Benha University, Egypt Methodology: The study was conducted on 75 Candida spp. isolated from various clinical samples of patients admitted in ICU. The Candida isolates were identified upto species level. Antifungal susceptibility testing was done by disc diffusion method. The biofilm formation was assessed by inoculating the isolates in conical polystyrene test tube containing Sabouraud’s dextrose broth supplemented with glucose. Proteinase activity was detected by using plates containing bovine serum albumin (BSA) agar. Phospholipase activity was detected by using egg yolk agar. Results: Seventy five Candida spp. were isolated from different clinical samples. C. albicans was isolated from 39(52%) samples. Non-albicans Candida (NAC) spp. were isolated from 36 (48%) clinical specimens. Forty one (54.7%) out of 75 Candida species isolates obtained from the clinical isolates produced biofilm. Out of 39 C. albicans isolates 20 (51.3%) produced biofilm, while out of 36 NAC species isolates 21 (58.3%) produced biofilm. The number of total proteinase positive isolates were 50 (66.7%). C. albicans was higher than that of the NAC isolates (29 [66.7%] versus 21 [58.3%]). Phospholipase positive isolates of C. albicans was higher than that of the NAC isolates (32[82.1%] versus 37[49.3%]). All isolates were susceptible to amphotericin B and ketoconazole. Resistance to fluconazole was found in 8 isolates (22.2%) of NAC spp. and 2 isolates (5.1%) of C. albicans isolates. Conclusion: The isolation of C. albicans were 39 (52%) in different clinical samples and isolation of NAC spp. were 36(48%). So NAC spp.  is no longer overlooked as these organisms are emerging pathogens. The number of NAC producing proteinase, phospholipase and biofilm are more than the number of C. albicans producing these virulence factors. The C. albicans and NAC showed 100% susceptiblity to amphotericin B  and ketokonazole while fluconazole showed resistance in 22.2% of NAC spp. and 5.1% of C. albicans isolates. All resistant Candida species to fluconazole were biofilm producers.

Candida species biofilm phospholipase proteinase

References (44)

  1. 1 District Laboratory Practice in Tropical Countries [DOI]
  2. 2 Candida Infections of Medical Devices [DOI]
  3. 3 Standardized Method for In Vitro Antifungal Susceptibility Testing of Candida albicans Biofilms [DOI]
  4. 4 CandidaBiofilms: an Update [DOI]
  5. 5 Plate method for detection of phospholipase activity inCandida albicans [DOI]
  6. 6 PUTATIVE VIRULENCE FACTORS OF CANDIDA ALBICANS [DOI]
  7. 7 Comparison of Biofilms Formed byCandidaalbicansandCandidaparapsilosison Bioprosthetic Surfaces [DOI]
  8. 8 Method for antifungal disk diffusion susceptibility testing of yeasts : Approved guideline
  9. 9 Biofilm lifestyle of Candida: a mini review [DOI]
  10. 10 Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies [DOI]
  11. 11 Application of CHROMagar Candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei, and Candida (Torulopsis) glabrata [DOI]
  12. 12 Virulence Factors in Candida species [DOI]
  13. 13 Biofilm formation in clinical Candida isolates and its association with virulence [DOI]
  14. 14 Virulence factors of Candida species.
  15. 15 Distribution of Candida Species in Different Clinical Samples and Their Virulence: Biofilm Formation, Proteinase and Phospholipase Production: A Study on Hospitalized Patients in Southern India [DOI]
  16. 16 Species distribution and antifungal susceptibility of Candida bloodstream isolates in Kuwait: a 10-year study [DOI]
  17. 17 Evidence implicating phospholipase as a virulence factor of Candida albicans [DOI]
  18. 18 Factors affecting the phospholipase activity ofCandidaspeciesin vitro [DOI]
  19. 19 A comparison of secretory proteinases from different strains ofCandida albicans [DOI]
  20. 20 Genotypic variation and slime production among blood and catheter isolates of Candida parapsilosis [DOI]
  21. 21 Phospholipase and protease activities in clinical Candida isolates with reference to the sources of strains [DOI]
  22. 22 Phospholipase, proteinase and haemolytic activities of Candida albicans isolated from oral cavities of patients with type 2 diabetes mellitus [DOI]
  23. 23 Biofilm Formation by and Antifungal Susceptibility of Candida Isolates from Urine [DOI]
  24. 24 Potential risk factors for infection with Candida spp. in critically ill patients [DOI]
  25. 25 In vitro evaluation of proteinase, phospholipase and haemolysin activities of Candida species isolated from clinical specimens [DOI]
  26. 26 Investigating Biofilm Production, Coagulase and Hemolytic Activity in Candida Species Isolated From Denture Stomatitis Patients [DOI]
  27. 27 In vitro differential activity of phospholipases and acid proteinases of clinical isolates of Candida [DOI]
  28. 28 Systemic Candida infection in University Hospital 1997–1999: the distribution of Candida biotypes and antifungal susceptibility patterns [DOI]
  29. 29 Evidence for a Role for Secreted Aspartate Proteinase of Candida albicans in Vulvovaginal Candidiasis [DOI]
  30. 30 Secreted aspartic proteases of Candida albicans, Candida tropicalis, Candida parapsilosis and Candida lusitaniae [DOI]
  31. 31 In Vitro Evaluation of Putative Virulence Attributes of Oral Isolates of Candida spp. Obtained from Elderly Healthy Individuals [DOI]
  32. 32 Catheter-Related Candidemia Caused byCandida lipolyticain a Patient Receiving Allogeneic Bone Marrow Transplantation [DOI]
  33. 33 Yeasts isolated from blood and catheter in children from a Public Hospital of São Paulo, Brazil [DOI]
  34. 34 Antifungal susceptibility testing of Candida tropicalis biofilms against fluconazole using calorimetric indicator resazurin [DOI]
  35. 35 Biofilm Formation and Antifungal Susceptibility of Candida Isolates from Various Clinical Specimens [DOI]
  36. 36 Isolation of Candida Species in clinical specimens and its virulence factor: The biofilm [DOI]
  37. 37 Speciation of candida by hicrome agar and sugar assimilation test in both hiv infected and non infected patients.
  38. 38 Evaluation of Phospholipase Activity in Biofilm Forming Candida Species Isolated from Intensive Care Unit Patients [DOI]
  39. 39 Multiple‐species candidemia in patients with cancer [DOI]
  40. 40 Exoenzymes Production and Antifungal Susceptibility of Candida Species Isolated from Pregnant Women with Vulvovaginitis
  41. 41 Characterization of fungal biofilm-based catheter-related sepsis [DOI]
  42. 42 [Results of antifungal susceptibility testing of Candida species and trends of antifungal use in Niigata university medical and dental hospital].
  43. 43 British Microbiology Research Journal [DOI]
  44. 44 Egyptian Journal of Medical Microbiology [DOI]

Cited by 8

Nosocomial Candiduria in Critically Ill Patients Admitted to Intensive Care Units in Menoufia University Hospitals, Egypt

Amira A. Alkilani, Abeer H. El Shalakany, Eman A. El-Masry, Elham T. Awad, Eman A. Mohamad · Journal of Advances in Medicine and Medical Research · 2016

Mycological Profile of Candida Tropicalis and its Virulence Factors from Candidemia Patients at A Tertiary Care Facility

Hemamalini Mohanraj, V. Vinodhini, L. Vajravelu · Journal of Pure and Applied Microbiology · 2023

Monitoring the Spectrum of Candidemia and its Anti-fungal Resistance in A Tertiary Care Centre – An Emerging Global Alarm

Pavithra Selvan, L. Vajravelu, Hemamalini Mohanraj · Journal of Pure and Applied Microbiology · 2022

Dynamics and metabolic profile of oral keratinocytes (NOK-si) and Candida albicans after interaction in co-culture

P. Masetti, P. Sanitá, J. Jorge · Biofouling (Print) · 2021

Species Distribution and in vitro Antifungal Susceptibility of Oropharyngeal Yeast Isolates from HIV Patients in Zewditu Memorial Hospital, Addis Ababa, Ethiopia

Birhanu Moges · 2014

ISOLATION AND IDENTIFICATION OF CANDIDA SPECIES FROM ORAL AND VAGINAL AND DETERMINATION OF VIRULENCE FACTOR

H. A. Ajah, A. Hassan, Ghufran Khalid Rahi · 2020

عزل وتوصيف خميرة (Candida glabrata) من عينات سريرية في بعض مستشفيات مدينة بغداد

ندى صادق صالح, محسن هاشم رسن, ثامر عبد الشهيد محسن · ​​​​Arabian Journal of Scientific Research-المجلة العربية للبحث العلمي · 2020

Showing 7 of 8 known citations — external sources report more than can currently be individually listed.

Related research

Article metrics

Real usage data collected on this platform.

79

Page views

0

PDF downloads

47

Outbound clicks

8

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.